CCAIM Announces Strategic Collaboration with Industry Leaders AstraZeneca, Boehringer Ingelheim, and GSK
Cambridge, 6 August 2024 - The Cambridge Centre for AI in Medicine (CCAIM) is pleased to announce a strategic collaboration with leading pharmaceutical companies AstraZeneca, Boehringer Ingelheim, and GSK. This collaboration aims to harness the power of artificial intelligence and machine learning to drive innovation in medical research and improve patient o
Department of Applied Mathematics and Theoretical Physics1y ago 
